GlassScriptPhysician profile
Christopher P Miller
NPI 1639598832
$19,541.81
in general payments reported to CMS, 2019-2025
11 companies · $696 in 2025
The $696 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $1,211 · 2021: $16K · 2022: $1,176 · 2023: $496 · 2024: $46.49 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187 · Travel and Lodging: $51.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.94 |
| Travel and Lodging | $51.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,000.00 | 2021 | |
| Globus Medical, INC. | $1,324.98 | 2019-2023 | Excelsiusgps Robotic Navigation System |
| Abbott Laboratories | $1,215.75 | 2021-2024 | Infinity, Proclaim |
| Medtronic, INC. | $1,037.46 | 2021-2025 | Percept PC Brainsense, Divergence Anterior Cervical Fusion System, Mazor X System |
| Nevro Corp. | $498.09 | 2021-2023 | Senza |
| Spineology INC. | $160.75 | 2025 | |
| Neuropace, INC. | $104.17 | 2019 | |
| Stryker Corporation | $65.95 | 2019 | |
| Depuy Synthes Sales INC. | $64.02 | 2019 | |
| Insightec,INC | $47.00 | 2022 | |
| Biocomposites INC | $23.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.